Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04750525 · ClinicalTrials.gov registry record · NA
A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 1)
A NA study of Pain Management, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT04750525: Completed NA study of Pain Management, sponsored by The University of Texas Health Science Center, Houston.
NCT04750525 is a NA study of Pain Management that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 15 participants, below the 154-participant average among 31 other Pain Management trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04750525, a NA study of Pain Management, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effectiveness of innovative intervention of breathing controlled electrical stimulation (BreEStim) and conventional electrical stimulation (EStim) in management of neuropathic phantom limb pain in patients after limb amputation.
Primary Outcome
VAS scores are recorded from 0 to 10 with 0 being "no pain" and 10 being "worst pain", a higher score indicating a higher level of pain. Change is reported as \[(VAS score at baseline) - (VAS Score 10 minutes after intervention)\] - a positive value indicates that the score (and pain level) decreased
Conditions Studied
Interventions
- DEVICE BreEStim
- DEVICE EStim
Study Locations (1)
Texas
- The University of Texas Health Science Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-04-02 |
| Est. Completion | 2023-03-10 |
| Phase | NA |
What the finished NCT04750525 record still lists
NCT04750525 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 154-participant average among 31 other Pain Management trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Pain Management appearing as the primary indexed condition, and to 2 interventions - of which BreEStim is the first listed.
NCT04750525 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04750525 about?
NCT04750525 is a clinical study titled "A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 1)". The purpose of this study is to compare the effectiveness of innovative intervention of breathing controlled electrical stimulation (BreEStim) and conventional electrical stimulation (EStim) in management of neuropathic phantom limb pain in patients after limb amputation.
What is the current status of trial NCT04750525?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-04-02. Estimated completion is 2023-03-10.
What conditions does trial NCT04750525 study?
This clinical trial studies the following conditions: Pain Management.
What interventions are being tested in trial NCT04750525?
The interventions under investigation include: BreEStim (DEVICE), EStim (DEVICE).
Who is sponsoring clinical trial NCT04750525?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04750525 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain Management
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04750525's enrollment target sits among peer trials
15 25th of 31 higher than 3 of 31 other Pain Management trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain Management trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app
RECRUITING · NA
-
mHealth Intervention for Pain Self Management
RECRUITING · NA
-
Sensory Spinal Cord Stimulation
RECRUITING · NA
-
Does Patient Testimonial Improve the Pain Relief Derived From a Brief Intervention
RECRUITING · NA
-
Post-Operative Analgesic Selection in Patients Planned for Third Molar Extraction After Undergoing Shared Decision Making Using 2- Versus 3-Option Decision-Aids
RECRUITING · NA
-
PEACE: Comparing Chronic Pain Treatment Options
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI